Showing results (1781-1790 of 1,838) with videos related to

Sort By:
Pageof 184
Journal of Palliative Medicine|May 30, 2020
EAN Guideline on Palliative Care of People with Severe, Progressive Multiple SclerosisAlessandra Solari, Andrea Giordano, Jaume Sastre-Garriga, et al.
European Journal of Neurology|July 24, 2018
Patient and caregiver involvement in the formulation of guideline questions: findings from the European Academy of Neurology guideline on palliative care of people with severe multiple sclerosisS Köpke, A Giordano, S Veronese, et al.
Health and Quality of Life Outcomes|June 25, 2023
Applying multidimensional computerized adaptive testing to the MSQOL-54: a simulation studyAndrea Giordano, Silvia Testa, Marta Bassi, et al.
Nature Chemistry|May 16, 2018
Fragment-derived inhibitors of human N-myristoyltransferase block capsid assembly and replication of the common cold virusAurélie Mousnier, Andrew S Bell, Dawid P Swieboda, et al.
Archives of Pediatrics & Adolescent Medicine|July 6, 2011
Sterile cerebrospinal fluid pleocytosis in young febrile infants with urinary tract infectionsDavid Schnadower, Nathan Kuppermann, Charles G Macias, et al.
Eclinicalmedicine|August 31, 2021
Corrigendum to Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial [EClinicalMedicine 37 (2021) 100,959]"Alejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, et al.
Health and Quality of Life Outcomes|September 26, 2021
Viability of a MSQOL-54 general health-related quality of life score using bifactor modelAndrea Giordano, Silvia Testa, Marta Bassi, et al.
Pediatrics|November 25, 2010
Febrile infants with urinary tract infections at very low risk for adverse events and bacteremiaDavid Schnadower, Nathan Kuppermann, Charles G Macias, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|November 11, 2019
Assessing measurement invariance of MSQOL-54 across Italian and English versionsAndrea Giordano, Silvia Testa, Marta Bassi, et al.
Eclinicalmedicine|June 30, 2021
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trialAlejandro Krolewiecki, Adrián Lifschitz, Matías Moragas, et al.
Pageof 184